Interaction Checker

Daptomisin etkileşimleri

antibiyotik sınıfından Daptomisin (Cubicin) için dizinlediğimiz FDA etiketlerinde ve bilgi sayfalarında 32 belgelenmiş etkileşim var: 0 majör, 32 orta, 0 minör ve bir etiketin anlamlı etkileşim olmadığını bildirdiği 0 çift. Aşağıdaki her kayıt, dayandığı cümleyi alıntılar. Bu ilaç sayfası bir başlangıç noktasıdır; sizin durumunuz için verilmiş bir hüküm değildir.

Etikete göre etkileşimler

Orta düzey etkileşimler (32)

  • Amlodipin ve atorvastatindihidropiridin kalsiyum kanal blokeriOrta

    In patients who receive Daptomycin for Injection, CPK levels should be monitored weekly, and more frequently in patients who received recent prior or concomitant therapy with an HMG-CoA reductase inhibitor or in whom elevations in CPK occur during treatment with Daptomycin for Injection. (Daptomisin etiketi, Uyarılar ve önlemler)

  • AtorvastatinstatinOrta

    In patients who receive Daptomycin for Injection, CPK levels should be monitored weekly, and more frequently in patients who received recent prior or concomitant therapy with an HMG-CoA reductase inhibitor or in whom elevations in CPK occur during treatment with Daptomycin for Injection. (Daptomisin etiketi, Uyarılar ve önlemler)

  • Azelastin ve flutikazonantihistaminikOrta

    Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (Daptomisin etiketi, Uyarılar ve önlemler)

  • BeklometazonkortikosteroidOrta

    Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (Daptomisin etiketi, Uyarılar ve önlemler)

  • BetametazonkortikosteroidOrta

    Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (Daptomisin etiketi, Uyarılar ve önlemler)

  • BudesonidkortikosteroidOrta

    Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (Daptomisin etiketi, Uyarılar ve önlemler)

  • Budesonid ve formoterolkortikosteroidOrta

    Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (Daptomisin etiketi, Uyarılar ve önlemler)

  • DeflazakortkortikosteroidOrta

    Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (Daptomisin etiketi, Uyarılar ve önlemler)

  • DeksametazonkortikosteroidOrta

    Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (Daptomisin etiketi, Uyarılar ve önlemler)

  • DesonidkortikosteroidOrta

    Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (Daptomisin etiketi, Uyarılar ve önlemler)

  • Ezetimib ve simvastatinstatinOrta

    In patients who receive Daptomycin for Injection, CPK levels should be monitored weekly, and more frequently in patients who received recent prior or concomitant therapy with an HMG-CoA reductase inhibitor or in whom elevations in CPK occur during treatment with Daptomycin for Injection. (Daptomisin etiketi, Uyarılar ve önlemler)

  • FludrokortizonkortikosteroidOrta

    Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (Daptomisin etiketi, Uyarılar ve önlemler)

  • FlunisolidkortikosteroidOrta

    Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (Daptomisin etiketi, Uyarılar ve önlemler)

  • FluosinonidkortikosteroidOrta

    Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (Daptomisin etiketi, Uyarılar ve önlemler)

  • FlutikazonkortikosteroidOrta

    Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (Daptomisin etiketi, Uyarılar ve önlemler)

  • Flutikazon ve salmeterolkortikosteroidOrta

    Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (Daptomisin etiketi, Uyarılar ve önlemler)

  • FluvastatinstatinOrta

    In patients who receive Daptomycin for Injection, CPK levels should be monitored weekly, and more frequently in patients who received recent prior or concomitant therapy with an HMG-CoA reductase inhibitor or in whom elevations in CPK occur during treatment with Daptomycin for Injection. (Daptomisin etiketi, Uyarılar ve önlemler)

  • HalobetazolkortikosteroidOrta

    Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (Daptomisin etiketi, Uyarılar ve önlemler)

  • HidrokortizonkortikosteroidOrta

    Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (Daptomisin etiketi, Uyarılar ve önlemler)

  • KlobetazolkortikosteroidOrta

    Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (Daptomisin etiketi, Uyarılar ve önlemler)

  • LovastatinstatinOrta

    In patients who receive Daptomycin for Injection, CPK levels should be monitored weekly, and more frequently in patients who received recent prior or concomitant therapy with an HMG-CoA reductase inhibitor or in whom elevations in CPK occur during treatment with Daptomycin for Injection. (Daptomisin etiketi, Uyarılar ve önlemler)

  • MetilprednizolonkortikosteroidOrta

    Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (Daptomisin etiketi, Uyarılar ve önlemler)

  • MometazonkortikosteroidOrta

    Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (Daptomisin etiketi, Uyarılar ve önlemler)

  • Olopatadin ve mometazonantihistaminikOrta

    Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (Daptomisin etiketi, Uyarılar ve önlemler)

  • PitavastatinstatinOrta

    In patients who receive Daptomycin for Injection, CPK levels should be monitored weekly, and more frequently in patients who received recent prior or concomitant therapy with an HMG-CoA reductase inhibitor or in whom elevations in CPK occur during treatment with Daptomycin for Injection. (Daptomisin etiketi, Uyarılar ve önlemler)

  • PravastatinstatinOrta

    In patients who receive Daptomycin for Injection, CPK levels should be monitored weekly, and more frequently in patients who received recent prior or concomitant therapy with an HMG-CoA reductase inhibitor or in whom elevations in CPK occur during treatment with Daptomycin for Injection. (Daptomisin etiketi, Uyarılar ve önlemler)

  • PrednizolonkortikosteroidOrta

    Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (Daptomisin etiketi, Uyarılar ve önlemler)

  • PrednizonkortikosteroidOrta

    Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (Daptomisin etiketi, Uyarılar ve önlemler)

  • RosuvastatinstatinOrta

    In patients who receive Daptomycin for Injection, CPK levels should be monitored weekly, and more frequently in patients who received recent prior or concomitant therapy with an HMG-CoA reductase inhibitor or in whom elevations in CPK occur during treatment with Daptomycin for Injection. (Daptomisin etiketi, Uyarılar ve önlemler)

  • SiklesonidkortikosteroidOrta

    Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (Daptomisin etiketi, Uyarılar ve önlemler)

  • SimvastatinstatinOrta

    In patients who receive Daptomycin for Injection, CPK levels should be monitored weekly, and more frequently in patients who received recent prior or concomitant therapy with an HMG-CoA reductase inhibitor or in whom elevations in CPK occur during treatment with Daptomycin for Injection. (Daptomisin etiketi, Uyarılar ve önlemler)

  • TriamsinolonkortikosteroidOrta

    Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (Daptomisin etiketi, Uyarılar ve önlemler)

Kullandığınız her şeyi Daptomisin ile karşılaştırın. Tüm listenizi ekleyin; her çift tek seferde kontrol edilir.

Sorgulama aracında aç

Tıbbi tavsiye değildir. Şiddet derecesi sizin koşullarınızı değil, etiketin ifadesini yansıtır. “Majör” işareti gözetim altında olağan bir uygulama olabilir, “minör” işareti ise yüksek dozlarda önem kazanabilir. Bir eczacıya danışın.